Inverse association between early-life weight status and perceptual reasoning, working memory scores
The focus on enhanced cognitive function could sideline equally important aspects of life such as health and relationships.
Preoperative cognitive function is a central component of predicting cognitive outcomes after resective epilepsy surgery.
Patients with schizophrenia, schizoaffective disorder, and psychotic bipolar disorder were examined for anticholinergic burden.
No between-group differences in measures of language, academic, or executive functioning were observed in those who took DHA during pregnancy and those who did not.
Previous research has suggested that statins and PCSK9 inhibitors may adversely affect cognition.
Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.
No correlation was found for cognitive function with changes in weight or fitness.
Researchers examined whether the cognitive reserve hypothesis could predict cognitive decline, gray matter volume changes, and white matter volume changes in MS patients.
Women who had high blood pressure while pregnant demonstrated later cognitive impairment and smaller brain volume compared with women who had normotensive pregnancies.
Neurology Advisor Articles
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Seizure Monitoring Smartwatch Cleared for Use in Children
- Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
- Can Early Initiation of Direct Oral Anticoagulants Prevent Recurrent AFib-Related Stroke?
- Online Family Problem-Solving Program May Improve Behavioral Outcomes in Older Children With TBI
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Risk for Conversion of MS Varies With Different Therapies
- Breakdown of Blood-Brain Barrier May Drive Dementia
- FDA: Food Inspections to Resume Despite Ongoing Funding Lapse
- First Generic Version of Sabril Tablets Gets FDA Approval
- Supine Positioning After Greater Occipital Nerve Block May Improve Outcomes